Study identifies potential new treatment options for people with endometrial cancer

Researchers at Huntsman Cancer Institute identified potential new treatment options for people with endometrial cancer.

AbbVie is gunning for accelerated approval of antibody-drug conjugate after positive PhII data

AbbVie plans to explore accelerated approval for its antibody-drug conjugate as a monotherapy in non-small cell lung cancer following positive Phase II topline data. Telisotuzumab-vedotin,

November 30, 2023

Ever-growing global diabetes burden exacerbated by large-scale inequity

Despite increased awareness and ongoing multinational efforts, diabetes is pervasive, exponentially growing in prevalence, and outpacing most diseases globally, according to a new Series published

July 5, 2023

Phasing out the ‘D-word’

As I roamed the meeting rooms and halls of the Alzheimer’s Association International Conference in Philadelphia last week, I kept hearing a word — dementia

August 5, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.